about
Real-time, portable genome sequencing for Ebola surveillanceExperimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in GuineaUnique human immune signature of Ebola virus disease in Guinea.Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa.Biofilm formation in an experimental water distribution system: the contamination of non-touch sensor taps and the implication for healthcare.Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.Cabinet Decontamination Using FormaldehydeHazard Group 3 agent decontamination using hydrogen peroxide vapour in a class III microbiological safety cabinet
P50
Q24283957-8E9839A4-C34F-4F25-BBD9-ACB7D0D6045AQ28550455-EE48C597-2E5F-4AFF-A0FC-0FAE8D49D13BQ34525050-E479D71A-EB46-4A2D-B6DC-1F72296CEE88Q37310771-4E45F149-CCF1-4417-9D3D-A84FAD2DF4E4Q38933098-E5953CCA-D9A8-4556-93F3-F0ACEE1CE3A2Q40877115-983957DB-C1A6-4481-ABB5-378029C0E486Q42916550-E0911F4E-2079-45E9-B8DE-51F75D7CB851Q56879357-C26EEFD8-1C3F-43E2-9C3F-5096AA4341E0Q90323357-AB522D8D-0D13-48CC-865B-32BE88AA25EA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Didier Ngabo
@ast
Didier Ngabo
@en
Didier Ngabo
@es
Didier Ngabo
@nl
Didier Ngabo
@sl
type
label
Didier Ngabo
@ast
Didier Ngabo
@en
Didier Ngabo
@es
Didier Ngabo
@nl
Didier Ngabo
@sl
prefLabel
Didier Ngabo
@ast
Didier Ngabo
@en
Didier Ngabo
@es
Didier Ngabo
@nl
Didier Ngabo
@sl
P106
P31
P496
0000-0003-1818-1439